Key facts
- Morus’s last known valuation is $13.0M (May 2025).
- It has raised $6.6M; the latest was Early Stage VC ($4.9M) in May 2025.
- Notable investors include SMBC Venture Capital, Mizuho Capital, ANRI, Japan Finance Corporation, DG Daiwa Ventures — 20 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 20 names
- ·Watchlist + deal alerts for Morus
- ·The full record, as it builds
Funding rounds
No funding rounds for Morus are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Morus
Developer of biomaterials of silkworm designed to supply favorably sustainable raw materials. The company offers powder made from whole silkworms with a natural flavour, essential amino acids, and distinct compounds, enabling multiple industries such as food, cosmetics, pharmaceuticals, and feed to utilise silkworms as a sustainable alternative protein.
- Sector
- Materials and Resources
- HQ
- Tokyo, Japan
- Founded
- 2021
- Employees
- 9
- Website
- morus.jp/
- Ownership
- Privately Held (backing)
Morus doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Morus shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Morus in its N-PORT filings yet. We sweep new filings monthly.